The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Open accessAbstract
Background The long-term health consequences of COVID-19 remain largely unclear. The aim of this study was to describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.Methods We did an ambidirectional cohort study of patients with confirmed COVID-19 who had been discharged from Jin Yin-tan Hospital (Wuhan, China) between Jan 7, 2020, and May 29, 2020. Patients who died before follow-up, patients for whom follow-up would be difficult because of psychotic disorders, dementia, or re-admission to hospital, those who were unable to move freely due to concomitant osteoarthropathy or immobile before or after discharge due to diseases such as stroke or pulmonary embolism, those who declined to participate, those who could not be contacted, and those living outside of Wuhan or in nursing or welfare homes were all excluded. All patients were interviewed with a series of questionnaires for evaluation of symptoms and health-related quality of life, underwent physical examinations and a 6-min walking test, and received blood tests. A stratified sampling procedure was used to sample patients according to their highest seven-category scale during their hospital stay as 3, 4, and 5-6, to receive pulmonary function test, high resolution CT of the chest, and ultrasonography. Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. Multivariable adjusted linear or logistic regression models were used to evaluate the association between disease severity and long-term health consequences.Findings In total, 1733 of 2469 discharged patients with COVID-19 were enrolled after 736 were excluded. Patients had a median age of 57·0 (IQR 47·0-65·0) years and 897 (52%) were men. The follow-up study was done from June 16, to Sept 3, 2020, and the median follow-up time after symptom onset was 186·0 (175·0-199·0) days. Fatigue or muscle weakness (63%, 1038 of 1655) and sleep difficulties (26%, 437 of 1655) were the most common symptoms. Anxiety or depression was reported among 23% (367 of 1617) of patients. The proportions of median 6-min walking distance less than the lower limit of the normal range were 24% for those at severity scale 3, 22% for severity scale 4, and 29% for severity scale 5-6. The corresponding proportions of patients with diffusion impairment were 22% for severity scale 3, 29% for scale 4, and 56% for scale 5-6, and median CT scores were 3·0 (IQR 2·0-5·0) for severity scale 3, 4·0 (3·0-5·0) for scale 4, and 5·0 (4·0-6·0) for scale 5-6. After multivariable adjustment, patients showed an odds ratio (OR) 1·61 (95% CI 0·80-3·25) for scale 4 versus scale 3 and 4·60 (1·85-11·48) for scale 5-6 versus scale 3 for diffusion impairment; OR 0·88 (0·66-1·17) for scale 4 versus scale 3 and OR 1·77 (1·05-2·97) for scale 5-6 versus scale 3 for anxiety or depression, and OR 0·74 (0·58-0·96) for scale 4 versus scale 3 and 2·69 (1·46-4·96) for scale 5-6 versus scale 3 for fatigue or muscle weakness. Of 94 patients with blood antibodies tested at follow-up, the seropositivity (96·2% vs 58·5%) and median titres (19·0 vs 10·0) of the neutralising antibodies were significantly lower compared with at the acute phase. 107 of 822 participants without acute kidney injury and with estimated glomerular filtration rate (eGFR) 90 mL/min per 1·73 m 2 or more at acute phase had eGFR less than 90 mL/min per 1·73 m 2 at follow-up.Interpretation At 6 months after acute infection, COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, and are the main target population for intervention of long-term recovery.Funding National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Key Research and Development Program of China, Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis, and Peking Union Medical College Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These mental health symptoms persist even after the acute stage of the disease.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Further, severe lung complications from COVID-19 may have persisting limitations to respiratory function and gas exchange; this group of patients, therefore, should be the primary target population for the intervention of long-term recovery.”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Abdominal chest imaging, and severe impairment to pulmonary diffusion capacities was reported in COVID-19 patients recovered from severe illness [32].”
From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [32]
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“These symptoms can endure up to 6–7 months and even longer [[1], [2], [3], [4], [5]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover [1,16].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
In the citing paper
“Literature data are not equivocal about the association between females and long COVID: some preliminary studies have shown an increased prevalence of fatigue [24] or other symptoms among women [1,5,13,16], while in other studies no gender association was found [4,[18], [19], [20]].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Standardization of Spirometry, 1994 Update. American Thoracic Society
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,605
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
Self-citationWiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)
Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., et al. (2020) · Radiology · doi:10.1148/radiol.2020200370 · Cited by 2,915
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,004
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study
Li, C., Liu, J., Lin, J., & Shang, H. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02052-3 · Cited by 150
Self-citationCurcumin as a Potential Treatment for COVID-19
Rattis, B. A. D. C., Ramos, S. G., & Celes, M. R. N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.675287 · Cited by 146
SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
El‐Boghdadly, K., Cook, T. M., Goodacre, T., Kua, J., Blake, L., Denmark, S., McNally, S., Mercer, N. S. G., Moonesinghe, R., & Summerton, D. J. (2021) · Anaesthesia · doi:10.1111/anae.15464 · Cited by 141
Munblit, D., Nicholson, T. R., Needham, D. M., Seylanova, N., Parr, C., Chen, J., Kokorina, A., Sigfrid, L., Buonsenso, D., Bhatnagar, S., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02222-y · Cited by 148
Kenny, G., McCann, K., O’Brien, C., Savinelli, S., Tinago, W., Yousif, O., Lambert, J. S., O’Broin, C., Feeney, E. R., de Barra, E., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac060 · Cited by 152
Li, J., Zhou, Y., Ma, J., Zhang, Q., Shao, J., Liang, S., Yu, Y., Li, W., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01640-z · Cited by 150
Self-citationInterleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
Kappelmann, N., Dantzer, R., & Khandaker, G. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105295 · Cited by 139
Italia, L., Tomasoni, D., Bisegna, S., Pancaldi, E., Stretti, L., Adamo, M., & Metra, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.713560 · Cited by 140
Cardiac involvement in the long-term implications of COVID-19
Satterfield, B. A., Bhatt, D. L., & Gersh, B. J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00631-3 · Cited by 138
The autonomic aspects of the post-COVID19 syndrome
Dotan, A., David, P., Arnheim, D., & Shoenfeld, Y. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103071 · Cited by 139
Pérez‐González, A., Araújo-Ameijeiras, A., Fernández‐Villar, A., Casal, M. C., Poveda, E., Cabrera, J. J., del Campo, V., de Araujo, B. G., Gómez, C., Leiro‐Fernández, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07414-x · Cited by 138
Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program
Brannock, M. D., Chew, R., Preiss, A., Hadley, E., Redfield, S., McMurry, J. A., Leese, P., Girvin, A. T., Crosskey, M., Zhou, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38388-7 · Cited by 138
Rando, H. M., Bennett, T. D., Byrd, J. B., Bramante, C. T., Callahan, T. J., Chute, C. G., Davis, H., Deer, R., Gagnier, J. J., Koraishy, F. M., et al. (2021) · medRxiv · doi:10.1101/2021.03.20.21253896 · Cited by 149
de Miranda, D. A. P., Gomes, S. V., Filgueiras, P. S., Corsini, C. A., Almeida, N. B. F., Silva, R. A., de Medeiros, M. I. V. D. A. R. C., Vilela, R. V., Fernandes, G. D. R., & Grenfell, R. F. Q. (2022) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trac030 · Cited by 137
Almeida, K. D. O., Alves, I. G. N., de Queiroz, R. S., de Castro, M. R., Gomes, V. A., Santos, F. C., Brites, C. R., & Neto, M. G. (2022) · Chronic Illness · doi:10.1177/17423953221089309 · Cited by 136
Long-term gastrointestinal outcomes of COVID-19
Xu, E., Xie, Y., & Al‐Aly, Z. (2023) · Nature Communications · doi:10.1038/s41467-023-36223-7 · Cited by 141
Lee, J. H., Yim, J., & Park, J. (2022) · Respiratory Research · doi:10.1186/s12931-022-02163-x · Cited by 142
Long COVID: An inevitable sequela of SARS-CoV-2 infection
Lai, C., Hsu, C., Yen, M., Lee, P., Ko, W., & Hsueh, P. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.10.003 · Cited by 135
Ashkenazi‐Hoffnung, L., Shmueli, E., Ehrlich, S., Ziv, A., Bar-On, O., Birk, E., Lowenthal, A., & Prais, D. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003285 · Cited by 140
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.09.001 · Cited by 139
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
Bellan, M., Baricich, A., Patrucco, F., Zeppegno, P., Gramaglia, C. M., Balbo, P. E., Carriero, A., Amico, C. S., Avanzi, G. C., Barini, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01215-4 · Cited by 140
King, R. G., Silva-Sánchez, A., Peel, J. N., Botta, D., Dickson, A. M., Pinto, A. K., Meza‐Perez, S., Allie, S. R., Schultz, M. D., Liu, M., et al. (2021) · Vaccines · doi:10.3390/vaccines9080881 · Cited by 134
Self-citationSex-Related Differences in Long-COVID-19 Syndrome
Pelà, G. M., Goldoni, M., Solinas, E., Cavalli, C., Tagliaferri, S., Ranzieri, S., Frizzelli, A., Marchi, L., Mori, P. A., Majori, M., et al. (2022) · Journal of Women s Health · doi:10.1089/jwh.2021.0411 · Cited by 139
Pazukhina, E., Andreeva, M., Spiridonova, E., Bobkova, P., Shikhaleva, A., El-Taravi, Y., Rumyantsev, M. A., Gamirova, A., Bairashevskaia, A., Petrova, P., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02448-4 · Cited by 138
Dinnon, K. H., Leist, S. R., Okuda, K., Dang, H., Fritch, E. J., Gully, K. L., la Cruz, G. D., Evangelista, M. D., Asakura, T., Gilmore, R. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo5070 · Cited by 138
Vojdani, A., Vojdani, E., Saidara, E., & Maes, M. H. J. (2023) · Viruses · doi:10.3390/v15020400 · Cited by 138
Herrera, J. E., Niehaus, W., Whiteson, J. H., Azola, A. M., Baratta, J. M., Fleming, T. K., Kim, S. Y., Naqvi, H., Sampsel, S., Silver, J. K., et al. (2021) · PM&R · doi:10.1002/pmrj.12684 · Cited by 137
Gut Microbiome Alterations in COVID-19
Zuo, T., Wu, X., Wen, W., & Lan, P. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.09.004 · Cited by 134
Pinato, D. J., Tabernero, J. M., Bower, M., Scotti, L., Patel, M., Colomba, É., Dolly, S. O., Loizidou, A., Chester, J. D., Mukherjee, U., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00573-8 · Cited by 134
SARS-CoV-2 in immunocompromised individuals
DeWolf, S., Laracy, J. C., Perales, M., Kamboj, M., van den Brink, M. R. M., & Vardhana, S. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.09.006 · Cited by 143
Hirschtick, J. L., Titus, A. R., Slocum, E. M., Power, L. E., Hirschtick, R. E., Elliott, M. R., McKane, P., & Fleischer, N. L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab408 · Cited by 133
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review
Ramadan, M. S., Bertolino, L., Zampino, R., Durante‐Mangoni, E., Durante‐Mangoni, E., Iossa, D., Bertolino, L., Ursi, M. P., D’Amico, F., Karruli, A., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.015 · Cited by 131
Cardiovascular Magnetic Resonance for Patients With COVID-19
Petersen, S. E., Friedrich, M. G., Leiner, T., Elias, M. D., Ferreira, V. M., Fenski, M., Flamm, S. D., Fogel, M. A., Garg, R., Halushka, M. K., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.08.021 · Cited by 131
Post-COVID syndrome prevalence: a systematic review and meta-analysis
Razak, R. S. A., Ismail, A., Aziz, A. F. A., Suddin, L. S., Azzeri, A. B., & Sha’ari, N. I. (2024) · BMC Public Health · doi:10.1186/s12889-024-19264-5 · Cited by 141
Vaes, A. W., Goërtz, Y. M. J., Herck, M. V., Machado, F. V. C., Meys, R., Delbressine, J. M., Houben‐Wilke, S., Gaffron, S., Maier, D., Burtin, C., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00141-2021 · Cited by 138
Long COVID‐19: Objectifying most self‐reported neurological symptoms
Bungenberg, J., Humkamp, K., Hohenfeld, C., Rust, M. I., Ermis, U., Dreher, M., Hartmann, N. K., Marx, G., Binkofski, F., Finke, C., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51496 · Cited by 137
Long COVID or post COVID-19 syndrome
Lechner‐Scott, J., Levy, M., Hawkes, C. H., Yeh, E. A., & Giovannoni, G. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103268 · Cited by 138
Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?
Dixit, N. M., Churchill, A., Nsair, A., & Hsu, J. J. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100025 · Cited by 129
Hodgson, C. L., Higgins, A. M., Bailey, M., Mather, A. M., Beach, L. J., Bellomo, R., Bissett, B., Boden, I. J., Bradley, S. J., Burrell, A. J. C., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03794-0 · Cited by 134
Long COVID in Children and Adolescents
Fainardi, V., Meoli, A., Chiopris, G., Motta, M., Skenderaj, K., Grandinetti, R., Bergomi, A., Antodaro, F., Zona, S., & Esposito, S. (2022) · Life · doi:10.3390/life12020285 · Cited by 135
Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
Bisaccia, G., Ricci, F., Recce, V., Serio, A., Iannetti, G., Chahal, A. A., Ståhlberg, M., Khanji, M. Y., Fedorowski, A., & Gallina, S. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110156 · Cited by 129
Cassar, M. P., Tunnicliffe, E. M., Petousi, N., Lewandowski, A. J., Xie, C., Mahmod, M., Samat, A. H. A., Evans, R. A., Brightling, C. E., Ho, L., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101159 · Cited by 132
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Iftekhar, E. N., Priesemann, V., Balling, R., Bauer, S., Beutels, P., Valdez, A. C., Cuschieri, S., Czypionka, T., Dumpis, U., Glaab, E., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100185 · Cited by 132
Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.
Asadi‐Pooya, A. A., Akbari, A., Emami, A., Lotfi, M., Rostamihosseinkhani, M., Nemati, H., Barzegar, Z., Kabiri, M., Zeraatpisheh, Z., Kouhanjani, M. F., et al. (2021) · PubMed Central · doi:10.30476/ijms.2021.92080.2326 · Cited by 142
Pathophysiology of Post-COVID syndromes: a new perspective
Batiha, G. E., Al-Kuraishy, H. M., Al-Gareeb, A. I., & Welson, N. N. (2022) · Virology Journal · doi:10.1186/s12985-022-01891-2 · Cited by 133
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19
Arjun, M. C., Singh, A. K., Pal, D., Das, K., Gajjala, A., Venkateshan, M., Mishra, B., Patro, B. K., Mohapatra, P. R., & Subba, S. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278825 · Cited by 131
Adeloye, D., Elneima, O., Daines, L., Poinasamy, K., Quint, J. K., Walker, S., Brightling, C. E., Siddiqui, S., Hurst, J. R., Chalmers, J. D., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00286-1 · Cited by 126
Peluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab640 · Cited by 128
Gastrointestinal sequelae 90 days after discharge for COVID-19
Weng, J., Li, Y., Li, J., Shen, L., Zhu, L., Liang, Y.-F., Lin, X., Jiao, N., Cheng, S., Huang, Y., et al. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00076-5 · Cited by 126
Self-citationChuang, H., Lin, C.-W., Hsiao, M., Wang, T., & Liang, H. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.03.022 · Cited by 125
Georgieva, E., Ananiev, J. R., Yovchev, Y., Arabadzhiev, G., Abrashev, H., Abrasheva, D., Atanasov, V. N., Kostandieva, R., Mitev, M., Petkova-Parlapanska, K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914876 · Cited by 129
Tran, V.-T., Riveros, C., Clepier, B., Desvarieux, M., Collet, C., Yordanov, Y., & Ravaud, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab352 · Cited by 130
Orrù, G., Bertelloni, D., Diolaiuti, F., Mucci, F., Giuseppe, M. D., Biella, M., Gemignani, A., Ciacchini, R., & Conversano, C. (2021) · Healthcare · doi:10.3390/healthcare9050575 · Cited by 124
Polly, M., de Almeida, B. L., Lennon, R. P., Côrtes, M. F., Costa, S. F., & Guimarães, T. (2021) · American Journal of Infection Control · doi:10.1016/j.ajic.2021.09.018 · Cited by 124
Neuropsychiatric aspects of long COVID : A comprehensive review
Kubota, T., Kuroda, N., & Sone, D. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13508 · Cited by 129
Lung Abnormalities Detected with Hyperpolarized 129 Xe MRI in Patients with Long COVID
Grist, J. T., Collier, G. J., Walters, H. L., Kim, M., Chen, M., Eid, G. A., Laws, A., Matthews, V., Jacob, K., Cross, S., et al. (2022) · Radiology · doi:10.1148/radiol.220069 · Cited by 123
Patel, M. A., Knauer, M. J., Nicholson, M., Daley, M., Nynatten, L. R. V., Martin, C. M., Patterson, E. K., Cepinskas, G., Seney, S. L., Dobretzberger, V., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00548-8 · Cited by 129
Strain, W. D., Sherwood, O., Banerjee, A., Van der Togt, V., Hishmeh, L., & Rossman, J. (2022) · Vaccines · doi:10.3390/vaccines10050652 · Cited by 122
Rapid vigilance and episodic memory decrements in COVID-19 survivors
Zhao, S., Shibata, K., Hellyer, P. J., Trender, W. R., Manohar, S., Hampshire, A., & Husain, M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab295 · Cited by 127
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Ahamed, J., & Laurence, J. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci161167 · Cited by 125
SARS-CoV-2 Invades the Central Nervous System via the Olfactory Route in Rhesus Monkeys
Li, J., Yang, Y., Yu, W., Zhao, Y., Long, H., Gao, J., Ding, K., Ma, C., Li, J., Zhao, S., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00591-7 · Cited by 126
Self-citationLong-term follow-up of recovered patients with COVID-19
Cortinovis, M., Perico, N., & Remuzzi, G. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00039-8 · Cited by 120
RetractedThe Impact of Post-COVID-19 Syndrome on Self-Reported Physical Activity
Delbressine, J. M., Machado, F. V. C., Goërtz, Y. M. J., Herck, M. V., Meys, R., Houben‐Wilke, S., Burtin, C., Franssen, F. M. E., Spies, Y., Vijlbrief, H., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18116017 · Cited by 127
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
Pérez‐Gómez, A., Vitallé, J., Gasca‐Capote, C., Gutiérrez‐Valencia, A., Trujillo‐Rodríguez, M., Serna‐Gallego, A., Muñoz‐Muela, E., Jiménez‐León, M. R., Benhnia, M. R., Rivas‐Jeremías, I., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00728-2 · Cited by 121
Fernández‐de‐las‐Peñas, C., Navarro‐Santana, M. J., Plaza‐Manzano, G., Palacios‐Ceña, D., & Arendt‐Nielsen, L. (2021) · Pain · doi:10.1097/j.pain.0000000000002496 · Cited by 125
Joshee, S. R., Vatti, N., & Chang, C. C.-C. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.12.017 · Cited by 118
Visco, V., Vitale, C., Rispoli, A., Izzo, C., Virtuoso, N., Ferruzzi, G. J., Santopietro, M., Melfi, A., Rusciano, M. R., Maglio, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030524 · Cited by 119
Cesaro, S., Ljungman, P. T., Mikulska, M., Hirsch, H. H., von Lilienfeld‐Toal, M., Cordonnier, C., Meylan, S., Mehra, V., Styczyński, J., Marchesi, F., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01578-1 · Cited by 120
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
Feng, C., Shi, J., Fan, Q., Wang, Y., Huang, H., Chen, F., Tang, G., Li, Y., Li, P., Li, J. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25312-0 · Cited by 120
Self-citationHejbøl, E. K., Harbo, T., Agergaard, J., Madsen, L. B., Pedersen, T. H., Østergaard, L. J., Andersen, H., Schrøder, H. D., & Tankişi, H. (2022) · European Journal of Neurology · doi:10.1111/ene.15435 · Cited by 123
Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)
Boscolo‐Rizzo, P., Guida, F., Polesel, J., Marcuzzo, A. V., Capriotti, V., D’Alessandro, A., Zanelli, E., Marzolino, R., Lazzarin, C., Antonucci, P., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22832 · Cited by 121
Thye, A. Y.-K., Law, J. W., Tan, L. T., Pusparajah, P., Ser, H., Thurairajasingam, S., Letchumanan, V., & Lee, L. (2022) · Biology · doi:10.3390/biology11010061 · Cited by 122
Sexual dimorphism in COVID-19: potential clinical and public health implications
Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00346-6 · Cited by 123
Selvakumar, J. P., Havdal, L. B., Drevvatne, M., Brodwall, E. M., Berven, L. L., Stiansen-Sonerud, T., Einvik, G., Leegaard, T. M., Tjade, T., Michelsen, A. E., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.5763 · Cited by 122
Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort
Westerlind, E., Palstam, A., Sunnerhagen, K. S., & Persson, H. (2021) · BMC Public Health · doi:10.1186/s12889-021-11013-2 · Cited by 122
Miller, F. A., Nguyen, V. G., Navaratnam, A. M. D., Shrotri, M., Kovar, J., Hayward, A. C., Fragaszy, E., Aldridge, R. W., Hardelid, P., & Collaborative, O. B. O. T. V. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003715 · Cited by 122
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
Ambardar, S., Hightower, S. L., Huprikar, N., Chung, K. K., SINGHAL, A. L., & Collen, J. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112452 · Cited by 120
Günster, C., Busse, R., Spoden, M., Rombey, T., Schillinger, G., Hoffmann, W. U., Weber‐Carstens, S., Schuppert, A., & Karagiannidis, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255427 · Cited by 116
Munipalli, B., Seim, L. A., Dawson, N. L., Knight, D. R. T., & Dabrh, A. M. A. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01167-4 · Cited by 118
Ong, S. W. X., Fong, S., Young, B. E., Chan, Y., Lee, B. T. K., Amrun, S. N., Chee, R. S., Yeo, N. K., Tambyah, P. A., Pada, S., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab156 · Cited by 113
Holmes, E. C., Wist, J., Masuda, R., Lodge, S., Nitschke, P., Kimhofer, T., Loo, R. L., Begum, S., Boughton, B. A., Yang, R., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00224 · Cited by 115
González-Hermosillo, J. A., Martínez-López, J., Carrillo-Lampón, S. A., Ruiz-Ojeda, D., Herrera-Ramírez, S., Amezcua-Guerra, L. M., & Martínez-Alvarado, M. R. (2021) · Brain Sciences · doi:10.3390/brainsci11060760 · Cited by 116
Long COVID and neuropsychiatric manifestations (Review)
Efstathiou, V., Stefanou, M., Demetriou, M., Siafakas, N., Makris, M. P., Tsivgoulis, G. K., Zoumpourlis, V., Kympouropoulos, S. P., Tsoporis, J. N., Spandidos, D. A., et al. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11290 · Cited by 118
Yoo, S. M., Liu, T. C., Motwani, Y., Sim, M., Viswanathan, N., Samras, N., Hsu, F., & Wenger, N. S. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07523-3 · Cited by 116
Du, M., Ma, Y., Deng, J., Liu, M., & Liu, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316010 · Cited by 113
Self-citationShi, L., Yuan, X., Yao, W., Wang, S., Zhang, C., Zhang, B., Song, J., Huang, L., Xu, Z., Fu, J., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103789 · Cited by 112
Self-citationToussi, S. S., Hammond, J., Gerstenberger, B. S., & Anderson, A. S. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01356-4 · Cited by 113
Steinbeis, F., Thibeault, C., Doellinger, F., Ring, R. M., Mittermaier, M., Ruwwe‐Glösenkamp, C., Alius, F., Knape, P., Meyer, H.-J., Lippert, L. J., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106709 · Cited by 121
Koczulla, A. R., Ankermann, T., Behrends, U., Berlit, P., Berner, R., Böing, S., Brinkmann, F., Frank, U., Franke, C., Glöckl, R., et al. (2022) · Pneumologie · doi:10.1055/a-1946-3230 · Cited by 118
Heightman, M., Prashar, J., Hillman, T. E., Marks, M., Livingston, R., Ridsdale, H. A., Roy, K., Bell, R., Zandi, M., McNamara, P., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001041 · Cited by 110
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
George, P. M., Reed, A. K., Desai, S. R., Devaraj, A., Faiez, T. S., Laverty, S., Kanwal, A., Esneau, C., Liu, M. K. P., Kamal, F., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo5795 · Cited by 112
Self-citationRadiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis
So, M., Kabata, H., Fukunaga, K., Takagi, H., & Kuno, T. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01463-0 · Cited by 114
Lorent, N., Weygaerde, Y. V., Claeys, E., Fajardo, I. G. C., Vos, N. D., Wever, W. D., Salhi, B., Gyselinck, I., Bosteels, C., Lambrecht, B. N., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00004-2022 · Cited by 109
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid
Krishna, B. A., Lim, E. Y., Metaxaki, M., Jackson, S. E., Mactavous, L., BioResource, N., Lyons, P., Döffinger, R., Bradley, J. R., Smith, K. G. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi9379 · Cited by 112
Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019
Szekely, Y., Lichter, Y., Sadon, S., Lupu, L., Taieb, P., Banai, A., Sapir, O. P. R., Granot, Y. N., Hochstadt, A., Friedman, S., et al. (2021) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2021.08.022 · Cited by 109
Fleischmann-Struzek, C., Rose, N., Freytag, A., Spoden, M., Prescott, H. C., Schettler, A., Wedekind, L., Ditscheid, B., Storch, J., Born, S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34290 · Cited by 106
Tleyjeh, I. M., Saddik, B. A., AlSwaidan, N., Alanazi, A. S., Ramakrishnan, R. K., Alhazmi, D., Aloufi, A., AlSumait, F., Berbari, E. F., & Halwani, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260568 · Cited by 117
Hossain, M. A., Hossain, K. M. A., Saunders, K., Uddin, Z., Walton, L. M., Raigangar, V. L., Sakel, M., Shafin, R., Hossain, M. S., Kabir, M. F., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006838 · Cited by 112
A living systematic review of the psychological problems in people suffering from COVID-19
Dong, F., Liu, H., Dai, N., Yang, M., & Liu, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.060 · Cited by 108
Wynberg, E., van Willigen, H. D. G., Dijkstra, M., Boyd, A. C., Kootstra, N. A., van den Aardweg, J. G., van Gils, M. J., Matser, A. A., de Wit, M. R., Leenstra, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab759 · Cited by 105
Metadata
- Authors
- Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., Li, Y., Xie, W., Cui, D., Shang, L., Fan, G., Xu, J., Wang, G., Wang, Y., Zhong, J., Wang, C., Wang, J., Zhang, D., & Cao, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Capital Medical University (CN)
- China-Japan Friendship Hospital (CN)
- Jinyintan Hospital (CN)
- Peking University (CN)
- Harbin Medical University (CN)
- Beijing University of Chinese Medicine (CN)
- Tsinghua University (CN)
- Corresponding author
- Cao, Bin
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10270
- Pages
- 220-232
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7833295
- OpenAlex
- W3120387768
- Cited by
- 4,084
- References
- 41
- Citations by year
- 2026: 67 · 2025: 180 · 2024: 510 · 2023: 934 · 2022: 1300 · 2021: 1088
- FWCI
- 458.37
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Project (2020ZX09201001)
- Chinese Academy of Medical Sciences (2020-I2M-CoV19\u2013005)
- National Natural Science Foundation of China (82041011/H0104)
- National Key Research and Development Program of China (2018YFC1200102)
- China-Japan Friendship Hospital
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, long-term health effects, long COVID, fatigue, muscle weakness, sleep disorders, anxiety, depression, disease severity, health-related quality of life, physical function, lung function, SARS-CoV-2, retraction, Wuhan, post-discharge follow-up, risk factors, lopinavir
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Post-Acute COVID-19 Syndrome, Aged, China, Fatigue, Female, Humans, Length of Stay, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Sleep Wake Disorders, Cohort Studies, Comorbidity, Muscle Weakness, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
